CN103893380A - Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny - Google Patents
Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny Download PDFInfo
- Publication number
- CN103893380A CN103893380A CN201210575751.7A CN201210575751A CN103893380A CN 103893380 A CN103893380 A CN 103893380A CN 201210575751 A CN201210575751 A CN 201210575751A CN 103893380 A CN103893380 A CN 103893380A
- Authority
- CN
- China
- Prior art keywords
- radix
- processed
- rhizoma
- herba
- parched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicinal preparation for treating vertebral hyperosteogeny. The traditional Chinese medicinal preparation comprises 5-25g of Millettia dielsiana, 5-20g of Salvia miltiorrhiza, 5-20g of Chinese angelica, 6-24g of Ligusticum wallichii, 5-25g of fried Radix Aconiti Ecalcarati, 5-25g of unprepared rehmannia root, 5-25g of prepared rehmannia root, 4-24g of fried Eucommia ulmoides, 5-25g of Chinese Taxillus Twig, 4-24g of fried Himalayan Teasel Root, 5-25g of fried Rhizoma Cibotii, 5-25g of fried Malaytea Scurfpea Fruit, 5-25g of fried Rhizoma Drynariae, 5-20g of Radix Clematidis, 5-25g of Medicinal Cyathula Root, 5-25g of Achyranthes bidentata, 5-20g of Incised Notopterygium, 5-20g of Radix Angelicae Pubescentis, 5-25g of Gentiana macrophylla, 2-20g of pawpaw, 2-20g of Divaricate Saposhnikovia Root, 2-20g of Radix Stephaniae Tetrandrae, 5-20g of Herba Aristolochiae Mollissimae, 2-20g of Sappanwood, 5-20g of Sambucus williamsii Hance, 5-20g of Radix Puerariae, 5-20g of Combined Spicebush Root, 2-18g of Herba Lycopi, 5-20g of Caulis Clematidis armandii, 5-20g of prepared Boswellia carteri, 5-20g of prepared myrrh, 3-12g of prepared Corydalis tuber, 3-12g of safflower, 3-12g of Cuscuta chinensis Lam., 2-20g of wolfberry fruit, 5-20g of cassia twig, 1-8g of Radix aconiti lateralis preparata and 5-20g of ground beetle. The traditional Chinese medicinal preparation for treating vertebral hyperosteogeny is mainly used for treating symptoms of lumbocrural pains, vertebral hyperosteogeny, intervertebral disc protrusion and femur head necrosis, and has the efficacies of essence and blood invigorating, tendon and muscle strengthening, marrow filling, vein relaxing and pain relieving.
Description
Technical field
The present invention relates to a kind of Chinese medicine, relate in particular to one and treat vertebrae hyperosteogeny Chinese medicine preparation.
Background technology
Vertebrae hyperosteogeny, intervertebral disk hernia, all can cause loin pain, " waist dash forward disease " is the abbreviation of prolapse of lumbar intervertebral disc.Prolapse of lumbar intervertebral disc is due to lumbar intervertebral disc degeneration, Anular disruption, a series of clinical symptoms and sign that the outstanding stimulation of vertebral pulp or pressuring neural root, cauda equina nerve show, be commonly called as in " waist dash forward disease ", be clinical commonly encountered diseases and cause the topmost reason of lumbago and skelalgia, the normal live and work of giving patient brings many miseries, even causes deformity, disability.Prolapse of lumbar intervertebral disc is the main cause of lumbago and skelalgia, is one of the most common illness of Orthopedic Clinical, accounts for the 10%-15% of Orthopaedics Clinic low back pain, and because of lumbago and skelalgia inpatient's 25%-40%.Prolapse of lumbar intervertebral disc is current frequently-occurring disease, and rehabilitation difficulty is larger, need to change irrational life style, so patient is badly in need for the treatment of rehabilitating, is returned to normal animation.The red Chinese medicine of reinforcing waist and strengthening bone can this type of disease of remissive treatment.
Summary of the invention
The object of this invention is to provide one and have nourishing kidney-yin, the kidney warming sun, fills out bone marrow, benefiting essence-blood, strengthening bone and muscle, blood circulation promoting and blood stasis dispelling, the treatment vertebrae hyperosteogeny Chinese medicine preparation of effect of removing obstruction in the collateral to relieve pain.
For realizing above object of the present invention, the present invention adopts following technical scheme:
One is treated vertebrae hyperosteogeny Chinese medicine preparation, it is characterized in that: its Chinese crude drug weight ratio ingredient is: Caulis Spatholobi 5～25g, Radix Salviae Miltiorrhizae 5～20g, Radix Angelicae Sinensis 5～20g, Rhizoma Chuanxiong 6～24g, fry BAIYAO 5～25g, each 5～the 25g of raw Radix Rehmanniae Preparata, Cortex Eucommiae (parched) 4～24g, Herba Taxilli 5～25g, fry Radix Dipsaci 4～24g, Rhizoma Cibotii 5～25g processed, Fructus Psoraleae (parched) 5～25g, Rhizoma Drynariae (processed) 5～25g, contain Radix Clematidis 5～20g, each 5～the 25g of river Radix Achyranthis Bidentatae, each 5～the 20g of Qiang's Radix Angelicae Pubescentis, Radix Gentianae Macrophyllae 5～25g, Fructus Chaenomelis 2～20g, Radix Saposhnikoviae 2～20g, Radix Stephaniae Tetrandrae 2～20g, Herba Aristolochiae Mollissimae 5～20g, Lignum Sappan 2～20g, Ramulus Sambuci Williamsii 5～20g, Radix Puerariae 5～20g, the Radix Linderae 5～20g, Herba Lycopi 2～18g, Caulis Clematidis Armandii 5～20g, breast processed does not have each 5～20g, Rhizoma Corydalis 3～12g processed, Flos Carthami 3～12g, Semen Cuscutae 3～12g, MEIQIZI 2～20g, Ramulus Cinnamomi 5～20g, Radix Aconiti Lateralis Preparata 1～8g, eupolyphaga 5～20g.
The present invention treats vertebrae hyperosteogeny Chinese medicine preparation, its preferably Chinese crude drug weight ratio ingredient is: Caulis Spatholobi 5～20g, Radix Salviae Miltiorrhizae 5～15g, Radix Angelicae Sinensis 10～20g, Rhizoma Chuanxiong 6～20g, fry BAIYAO 5～20g, each 5～the 20g of raw Radix Rehmanniae Preparata, Cortex Eucommiae (parched) 4～20g, Herba Taxilli 5～20g, fry Radix Dipsaci 4～20g, Rhizoma Cibotii 10～25g processed, Fructus Psoraleae (parched) 10～25g, Rhizoma Drynariae (processed) 10～25g, contain Radix Clematidis 5～15g, each 10～the 25g of river Radix Achyranthis Bidentatae, each 10～the 20g of Qiang's Radix Angelicae Pubescentis, Radix Gentianae Macrophyllae 10～25g, Fructus Chaenomelis 5～20g, Radix Saposhnikoviae 5～20g, Radix Stephaniae Tetrandrae 5～20g, Herba Aristolochiae Mollissimae 10～20g, Lignum Sappan 8～20g, Ramulus Sambuci Williamsii 8～20g, Radix Puerariae 10～18g, the Radix Linderae 10～18g, Herba Lycopi 2～16g, Caulis Clematidis Armandii 10～20g, breast processed does not have each 10～20g, Rhizoma Corydalis 3～10g processed, Flos Carthami 3～10g, Semen Cuscutae 3～10g, MEIQIZI 5～20g, Ramulus Cinnamomi 10～20g, Radix Aconiti Lateralis Preparata 2～8g, eupolyphaga 8～20g.
The present invention treats vertebrae hyperosteogeny Chinese medicine preparation, its better Chinese crude drug weight ratio ingredient is: Caulis Spatholobi 10g, Radix Salviae Miltiorrhizae 10g, Radix Angelicae Sinensis 18g, Rhizoma Chuanxiong 18g, fry BAIYAO 10g, the each 10g of raw Radix Rehmanniae Preparata, Cortex Eucommiae (parched) 18g, Herba Taxilli 18g, fry Radix Dipsaci 18g, Rhizoma Cibotii 18g processed, Fructus Psoraleae (parched) 18g, Rhizoma Drynariae (processed) 18g, contain Radix Clematidis 12g, the each 10g of river Radix Achyranthis Bidentatae, the each 10g of Qiang's Radix Angelicae Pubescentis, Radix Gentianae Macrophyllae 10g, Fructus Chaenomelis 10g, Radix Saposhnikoviae 6g, Radix Stephaniae Tetrandrae 6g, Herba Aristolochiae Mollissimae 10g, Lignum Sappan 10g, Ramulus Sambuci Williamsii 10g, Radix Puerariae 10g, Radix Linderae 10g, Herba Lycopi 10g, Caulis Clematidis Armandii 10g, breast processed does not have each 10g, Rhizoma Corydalis 6g processed, Flos Carthami 6g, Semen Cuscutae 10g, MEIQIZI 10g, Ramulus Cinnamomi 10g, Radix Aconiti Lateralis Preparata 3g, eupolyphaga 10g.
Preparation method: adopt warm fire to decoct, concentrated after filtering, pack in bottle, every bottled enter 300ml, every bottle adds the Mel of 15ml in addition, encapsulates for subsequent use.
Take beneficial effect of the present invention: be mainly used in treating the symptoms such as lumbago and skelalgia, vertebrae hyperosteogeny, intervertebral disk hernia, femur head necrosis, there is benefiting essence-blood, strengthening bone and muscle, blood circulation promoting and blood stasis dispelling, fills out bone marrow, effect of removing obstruction in the collateral to relieve pain.
Below in conjunction with clinical testing data, beneficial effect of the present invention is described:
1,, from year May in March, 2011 to 2012, the inventor applies the made pill of the present invention and observes treatment 100 routine lumbago and skelalgia, vertebrae hyperosteogeny, intervertebral disk hernia, Patients with Aseptic Necrosis of Femoral, the oldest person 60 years old, age reckling 40 years old, 50 years old mean age.
2, diagnostic criteria: lumbago and skelalgia, vertebrae hyperosteogeny, intervertebral disk hernia, femur head necrosis.
3, Therapeutic Method: refined honey becomes ball, every day three times, each ball, one hour ante cibum of morning, noon and afternoon takes, and be three months each course for the treatment of.
4, criterion of therapeutical effect:
Cure: symptom and clinical sign disappear, other objective determination index normals;
Effective: symptom and clinical sign alleviate, other objective determination indexs are obviously improved;
Invalid: symptom and clinical sign do not change, other objective determination indexs are to some extent obviously improved.
5, therapeutic outcome: 100 routine patients are observed through the treatment of three courses for the treatment of, and 80 routine patients obtain curative effect, the effective effect of 15 routine patient, 5 routine patient treatments are invalid, total effective rate 95%.
The specific embodiment
Below in conjunction with embodiment more specifically, the present invention is done to further expansion explanation, but it is pointed out that the present invention treats vertebrae hyperosteogeny Chinese medicine preparation and is not limited to this concrete component or form.
Formula one:
Caulis Spatholobi 5～25g, Radix Salviae Miltiorrhizae 5～20g, Radix Angelicae Sinensis 5～20g, Rhizoma Chuanxiong 6～24g, fry BAIYAO 5～25g, each 5～the 25g of raw Radix Rehmanniae Preparata, Cortex Eucommiae (parched) 4～24g, Herba Taxilli 5～25g, fry Radix Dipsaci 4～24g, Rhizoma Cibotii 5～25g processed, Fructus Psoraleae (parched) 5～25g, Rhizoma Drynariae (processed) 5～25g, contain Radix Clematidis 5～20g, each 5～the 25g of river Radix Achyranthis Bidentatae, each 5～the 20g of Qiang's Radix Angelicae Pubescentis, Radix Gentianae Macrophyllae 5～25g, Fructus Chaenomelis 2～20g, Radix Saposhnikoviae 2～20g, Radix Stephaniae Tetrandrae 2～20g, Herba Aristolochiae Mollissimae 5～20g, Lignum Sappan 2～20g, Ramulus Sambuci Williamsii 5～20g, Radix Puerariae 5～20g, the Radix Linderae 5～20g, Herba Lycopi 2～18g, Caulis Clematidis Armandii 5～20g, breast processed does not have each 5～20g, Rhizoma Corydalis 3～12g processed, Flos Carthami 3～12g, Semen Cuscutae 3～12g, MEIQIZI 2～20g, Ramulus Cinnamomi 5～20g, Radix Aconiti Lateralis Preparata 1～8g, eupolyphaga 5～20g.
Formula two:
Caulis Spatholobi 5～20g, Radix Salviae Miltiorrhizae 5～15g, Radix Angelicae Sinensis 10～20g, Rhizoma Chuanxiong 6～20g, fry BAIYAO 5～20g, each 5～the 20g of raw Radix Rehmanniae Preparata, Cortex Eucommiae (parched) 4～20g, Herba Taxilli 5～20g, fry Radix Dipsaci 4～20g, Rhizoma Cibotii 10～25g processed, Fructus Psoraleae (parched) 10～25g, Rhizoma Drynariae (processed) 10～25g, contain Radix Clematidis 5～15g, each 10～the 25g of river Radix Achyranthis Bidentatae, each 10～the 20g of Qiang's Radix Angelicae Pubescentis, Radix Gentianae Macrophyllae 10～25g, Fructus Chaenomelis 5～20g, Radix Saposhnikoviae 5～20g, Radix Stephaniae Tetrandrae 5～20g, Herba Aristolochiae Mollissimae 10～20g, Lignum Sappan 8～20g, Ramulus Sambuci Williamsii 8～20g, Radix Puerariae 10～18g, the Radix Linderae 10～18g, Herba Lycopi 2～16g, Caulis Clematidis Armandii 10～20g, breast processed does not have each 10～20g, Rhizoma Corydalis 3～10g processed, Flos Carthami 3～10g, Semen Cuscutae 3～10g, MEIQIZI 5～20g, Ramulus Cinnamomi 10～20g, Radix Aconiti Lateralis Preparata 2～8g, eupolyphaga 8～20g.
Formula three:
Caulis Spatholobi 10g, Radix Salviae Miltiorrhizae 10g, Radix Angelicae Sinensis 18g, Rhizoma Chuanxiong 18g, fry BAIYAO 10g, the each 10g of raw Radix Rehmanniae Preparata, Cortex Eucommiae (parched) 18g, Herba Taxilli 18g, fry Radix Dipsaci 18g, Rhizoma Cibotii 18g processed, Fructus Psoraleae (parched) 18g, Rhizoma Drynariae (processed) 18g, contain Radix Clematidis 12g, the each 10g of river Radix Achyranthis Bidentatae, the each 10g of Qiang's Radix Angelicae Pubescentis, Radix Gentianae Macrophyllae 10g, Fructus Chaenomelis 10g, Radix Saposhnikoviae 6g, Radix Stephaniae Tetrandrae 6g, Herba Aristolochiae Mollissimae 10g, Lignum Sappan 10g, Ramulus Sambuci Williamsii 10g, Radix Puerariae 10g, Radix Linderae 10g, Herba Lycopi 10g, Caulis Clematidis Armandii 10g, breast processed does not have each 10g, Rhizoma Corydalis 6g processed, Flos Carthami 6g, Semen Cuscutae 10g, MEIQIZI 10g, Ramulus Cinnamomi 10g, Radix Aconiti Lateralis Preparata 3g, eupolyphaga 10g.
The present invention treats vertebrae hyperosteogeny Chinese medicine preparation, adopts effect that described various Chinese medicine has and effect respectively: Caulis Spatholobi: enrich blood, invigorate blood circulation, dredging collateral; Radix Salviae Miltiorrhizae: removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Radix Angelicae Sinensis: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving; Rhizoma Chuanxiong: blood circulation promoting and blood stasis dispelling; Radix Paeoniae Alba (parched): nourishing blood to suppress the hyperactive liver, slow middle pain relieving; The raw Radix Rehmanniae Preparata YIN nourishing of enriching blood, vital essence replenishing and marrow benifiting; Cortex Eucommiae (parched): invigorating the liver and kidney, bone and muscle strengthening; Herba Taxilli: the liver and the kidney tonifying, promoting blood circulation, wind-damp dispelling; Fry Radix Dipsaci: invigorating the liver and kidney, bone and muscle strengthening, sharp joint; Rhizoma Cibotii processed: expelling wind and removing dampness, invigorating the liver and kidney, bone and muscle strengthening; Fructus Psoraleae (parched): kidney invigorating and YANG supporting; Rhizoma Drynariae (processed): tonify deficiency, supporing yang, the kidney invigorating bone strengthening, promoting blood circulation and stopping pain; Contain Radix Clematidis: loose wind damp eliminating, promoting blood circulation and stopping pain; River Radix Achyranthis Bidentatae is each: nourishing the liver and kidney, strong waist knee joint; Qiang's Radix Angelicae Pubescentis is each: expelling wind and dampness, pain relieving; Radix Gentianae Macrophyllae: wind-damp dispelling, reducing the asthenic fever, pain relieving; Fructus Chaenomelis: suppressing the hyperactive liver dispels the wind, scattered silt is invigorated blood circulation; Radix Saposhnikoviae: dispersing wind and cold, loose wind heat; Radix Stephaniae Tetrandrae: expelling wind and cold, logical Lip river pain relieving; Herba Aristolochiae Mollissimae: dispelling wind and removing obstruction in the collateral, pain relieving; Lignum Sappan: blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain; Ramulus Sambuci Williamsii: expelling wind and removing dampness, promoting blood circulation and hemostasis; Radix Puerariae: yang invigorating expelling pathogenic factors from muscles, rash antidiarrheal, relieving restlessness is quenched the thirst; The Radix Linderae: dissipating depression of QI, cold expelling, pain relieving; Herba Lycopi: blood circulation promoting and blood stasis dispelling; Caulis Clematidis Armandii: clearing away heat and promoting diuresis, dysmenorrhea stimulating milk secretion; System breast is not each: detumescence, relieve oedema or abdominal distension through diuresis or purgation, and diuresis, pain relieving; Rhizoma Corydalis processed: invigorate blood circulation, circulation of qi promoting, pain relieving; Flos Carthami: the latus rectum of invigorating blood circulation, eliminating stasis to stop pain; Semen Cuscutae: invigorating the liver and kidney, beneficial marrow, improving eyesight; MEIQIZI: anti-fatty liver, regulates blood fat; Ramulus Cinnamomi: cure by diaphoresis flesh, warming the meridian and promoting blood circulation; Radix Aconiti Lateralis Preparata: mend fire supporing yang, dispersing cold for relieving pain; Eupolyphaga: activating blood circulation and dissipating phlegm.
Treatment example 1:
Jiang, female, Mingguang, anhui people from city, 43 years old, takes front symptom: lumbago and skelalgia.Take after the course for the treatment of of this Chinese medicine, pain alleviates to some extent, then takes 20, without pain, and recovery from illness.
Treatment example 2:
Chen, man, Mingguang, anhui people from city, 55 years old, takes front symptom: vertebrae hyperosteogeny.Take after the course for the treatment of of this Chinese medicine, vertebrae hyperosteogeny disappears, without pain, and recovery from illness.
Treatment example 3:
Lee, female, Mingguang, anhui people from city, 60 years old, takes front symptom: vertebra asks that dish is outstanding, femur head necrosis.Take after the course for the treatment of of this Chinese medicine, intervertebral disk hernia disappears, femur head necrosis transference cure, and pain alleviates to some extent, then takes after two courses for the treatment of, recovery from illness.
Although above the specific embodiment of the present invention has been given to describe in detail and explanation; but what should indicate is; we can carry out various equivalences to above-mentioned embodiment according to conception of the present invention and change and revise; when its function producing does not exceed spiritual that description contains yet, all should be within protection scope of the present invention.
Claims (3)
1. a treatment vertebrae hyperosteogeny Chinese medicine preparation, it is characterized in that: its Chinese crude drug weight ratio ingredient is: Caulis Spatholobi 5～25g, Radix Salviae Miltiorrhizae 5～20g, Radix Angelicae Sinensis 5～20g, Rhizoma Chuanxiong 6～24g, fry BAIYAO 5～25g, each 5～the 25g of raw Radix Rehmanniae Preparata, Cortex Eucommiae (parched) 4～24g, Herba Taxilli 5～25g, fry Radix Dipsaci 4～24g, Rhizoma Cibotii 5～25g processed, Fructus Psoraleae (parched) 5～25g, Rhizoma Drynariae (processed) 5～25g, contain Radix Clematidis 5～20g, each 5～the 25g of river Radix Achyranthis Bidentatae, each 5～the 20g of Qiang's Radix Angelicae Pubescentis, Radix Gentianae Macrophyllae 5～25g, Fructus Chaenomelis 2～20g, Radix Saposhnikoviae 2～20g, Radix Stephaniae Tetrandrae 2～20g, Herba Aristolochiae Mollissimae 5～20g, Lignum Sappan 2～20g, Ramulus Sambuci Williamsii 5～20g, Radix Puerariae 5～20g, the Radix Linderae 5～20g, Herba Lycopi 2～18g, Caulis Clematidis Armandii 5～20g, breast processed does not have each 5～20g, Rhizoma Corydalis 3～12g processed, Flos Carthami 3～12g, Semen Cuscutae 3～12g, MEIQIZI 2～20g, Ramulus Cinnamomi 5～20g, Radix Aconiti Lateralis Preparata 1～8g, eupolyphaga 5～20g.
2. treatment vertebrae hyperosteogeny Chinese medicine preparation according to claim 1, it is characterized in that: its Chinese crude drug weight ratio ingredient is: Caulis Spatholobi 5～20g, Radix Salviae Miltiorrhizae 5～15g, Radix Angelicae Sinensis 10～20g, Rhizoma Chuanxiong 6～20g, fry BAIYAO 5～20g, each 5～the 20g of raw Radix Rehmanniae Preparata, Cortex Eucommiae (parched) 4～20g, Herba Taxilli 5～20g, fry Radix Dipsaci 4～20g, Rhizoma Cibotii 10～25g processed, Fructus Psoraleae (parched) 10～25g, Rhizoma Drynariae (processed) 10～25g, contain Radix Clematidis 5～15g, each 10～the 25g of river Radix Achyranthis Bidentatae, each 10～the 20g of Qiang's Radix Angelicae Pubescentis, Radix Gentianae Macrophyllae 10～25g, Fructus Chaenomelis 5～20g, Radix Saposhnikoviae 5～20g, Radix Stephaniae Tetrandrae 5～20g, Herba Aristolochiae Mollissimae 10～20g, Lignum Sappan 8～20g, Ramulus Sambuci Williamsii 8～20g, Radix Puerariae 10～18g, the Radix Linderae 10～18g, Herba Lycopi 2～16g, Caulis Clematidis Armandii 10～20g, breast processed does not have each 10～20g, Rhizoma Corydalis 3～10g processed, Flos Carthami 3～10g, Semen Cuscutae 3～10g, MEIQIZI 5～20g, Ramulus Cinnamomi 10～20g, Radix Aconiti Lateralis Preparata 2～8g, eupolyphaga 8～20g.
3. treatment vertebrae hyperosteogeny Chinese medicine preparation according to claim 1, it is characterized in that: its Chinese crude drug weight ratio ingredient is: Caulis Spatholobi 10g, Radix Salviae Miltiorrhizae 10g, Radix Angelicae Sinensis 18g, Rhizoma Chuanxiong 18g, fry BAIYAO 10g, the each 10g of raw Radix Rehmanniae Preparata, Cortex Eucommiae (parched) 18g, Herba Taxilli 18g, fry Radix Dipsaci 18g, Rhizoma Cibotii 18g processed, Fructus Psoraleae (parched) 18g, Rhizoma Drynariae (processed) 18g, contain Radix Clematidis 12g, the each 10g of river Radix Achyranthis Bidentatae, the each 10g of Qiang's Radix Angelicae Pubescentis, Radix Gentianae Macrophyllae 10g, Fructus Chaenomelis 10g, Radix Saposhnikoviae 6g, Radix Stephaniae Tetrandrae 6g, Herba Aristolochiae Mollissimae 10g, Lignum Sappan 10g, Ramulus Sambuci Williamsii 10g, Radix Puerariae 10g, Radix Linderae 10g, Herba Lycopi 10g, Caulis Clematidis Armandii 10g, breast processed does not have each 10g, Rhizoma Corydalis 6g processed, Flos Carthami 6g, Semen Cuscutae 10g, MEIQIZI 10g, Ramulus Cinnamomi 10g, Radix Aconiti Lateralis Preparata 3g, eupolyphaga 10g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210575751.7A CN103893380A (en) | 2012-12-27 | 2012-12-27 | Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210575751.7A CN103893380A (en) | 2012-12-27 | 2012-12-27 | Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103893380A true CN103893380A (en) | 2014-07-02 |
Family
ID=50985164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210575751.7A Pending CN103893380A (en) | 2012-12-27 | 2012-12-27 | Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103893380A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104127625A (en) * | 2014-08-01 | 2014-11-05 | 张媛媛 | Traditional Chinese medicine for treating hyperosteogeny |
| CN104474293A (en) * | 2014-10-17 | 2015-04-01 | 朱留臣 | Traditional Chinese medicine ointment for treating hyperosteogeny and preparing method thereof |
| CN105031405A (en) * | 2015-08-26 | 2015-11-11 | 赵光明 | Gufukang for treating hyperostosis |
| CN105687917A (en) * | 2016-04-25 | 2016-06-22 | 沙宗跃 | Oral solution for treating arthritis |
| CN106039052A (en) * | 2016-06-03 | 2016-10-26 | 桓大卫 | External-application Du-channel-dredging bonesetting liquid and preparation method thereof |
-
2012
- 2012-12-27 CN CN201210575751.7A patent/CN103893380A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104127625A (en) * | 2014-08-01 | 2014-11-05 | 张媛媛 | Traditional Chinese medicine for treating hyperosteogeny |
| CN104474293A (en) * | 2014-10-17 | 2015-04-01 | 朱留臣 | Traditional Chinese medicine ointment for treating hyperosteogeny and preparing method thereof |
| CN105031405A (en) * | 2015-08-26 | 2015-11-11 | 赵光明 | Gufukang for treating hyperostosis |
| CN105031405B (en) * | 2015-08-26 | 2019-03-05 | 赵光明 | The bone for treating hyperosteogeny answers health |
| CN105687917A (en) * | 2016-04-25 | 2016-06-22 | 沙宗跃 | Oral solution for treating arthritis |
| CN106039052A (en) * | 2016-06-03 | 2016-10-26 | 桓大卫 | External-application Du-channel-dredging bonesetting liquid and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327380A (en) | Chinese medicinal composition for treating knee osteoarthritis | |
| CN103463241A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
| CN103893380A (en) | Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny | |
| CN103520579A (en) | Medicinal liquor used for treating lumbocrural pain, hyperostosis and sciatica | |
| CN103933200B (en) | A kind of Chinese medicine composition for the treatment of apoplexy sequela | |
| CN105560662A (en) | External-use traditional Chinese medicine composition for treating knee osteoarthritis | |
| CN101507802A (en) | Medicine for treating ankylosing spondylitis | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN103142938A (en) | Plaster for treating traumatic injury and fracture | |
| CN102626505A (en) | Massaging paste based on Chinese medicinal herbs and preparation method thereof | |
| CN102784208B (en) | Medicament for treating lumbar disc herniation and preparation method thereof | |
| CN103446360B (en) | Traditional Chinese medicine capsule preparation for treating lumbar disc herniation and preparation method of traditional Chinese medicine capsule preparation | |
| CN102283929A (en) | Chinese medicinal composition for treating talalgia | |
| CN104740142A (en) | Traditional Chinese medicine for treating sciatica | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN106511905A (en) | Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof | |
| CN105687570A (en) | Traditional Chinese medicinal composition for treating sciatica | |
| CN101810756B (en) | Plaster for treating lumbar | |
| CN104606313A (en) | Traditional Chinese medicinal ointment for treating osteoarticular diseases and bone fractures | |
| CN104173934A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN104740003A (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN102430066B (en) | Sciatic nerve liquid | |
| CN101637535B (en) | Medicine for treating bone hyperplasia and preparation method thereof | |
| CN109010682B (en) | Traditional Chinese medicine composition for treating central nervous function damage and warming governor vessel, eliminating turbid pathogen and dredging collaterals | |
| CN101219202A (en) | Soup for strengthening tendon and waist |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140702 |